
IMHOTEP, PJP, and more
May 14, 2026 - 00:09:59
Radio and PodcastLive Radio & Podcasts
We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing). Also, pembrolizumab nets another approval, this time in conjunction with paclit...
Axi-Cel and 5-FU Label Changes is an episode from OncoPharm by OncoPharmPod. We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing). Also, pembrolizumab ne...
This episode belongs to OncoPharm.
Use the player on this page to stream the episode online.
Published Feb 12, 2026, 00:12:34 long, audio available.
We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing). Also, pembrolizumab nets another approval, this time in conjunction with paclitaxel for platinum-resistant ovarian cancer (limited to PD-L1 CPS of 1% of greater)
You can listen to Axi-Cel and 5-FU Label Changes online on Radio and Podcast. Open the player on this page to stream the available audio.
Axi-Cel and 5-FU Label Changes is an episode from OncoPharm by OncoPharmPod.
This episode is 00:12:34 long.
This episode was published on Feb 12, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.